Vector development: A major obstacle in human gene therapy

Annals of Medicine

Volumn 30, Issue 5, 1998, Pages 413-415

  Jane, Stephen M ^a   Cunningham, John M ^b   Vanin, Elio F ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CANCER; EDITORIAL; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMOGLOBINOPATHY; HUMAN; IMMUNE DEFICIENCY; METHODOLOGY; MONOGENIC DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TRANSGENE;

EID: 0031785892     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899809002481     Document Type: Editorial

References (9)

1. Anderson WF. Human gene therapy (review). Nature 1998; 392 (6679 Suppl): 25-30.
2. Nienhuis AW, Walsh CE, Liu J. Viruses as therapeutic gene transfer vectors. In: Young NS, ed. Viruses and Bone Marrow. New York: Marcell Dekker 1993: 353-414.
3. Langer R. Drug delivery and targeting (review). Nature 1998; 392 (6679 Suppl): 5-10.
4. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Nat Acad Sci USA 1996; 93: 11097-102
5. Havenga M, Hoogerbrugge P, Valerio D, van Es HHG. Retroviral stem cell gene therapy. Stem Cells 1997; 15: 162-79.
6. Schnierle BS, Groner B. Retroviral targeted delivery. Gene Ther 1996; 3: 1069-73.
7. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996; 272: 263-7.
8. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185-7.
9. Fisher KJ, Jooss K, Alston J, et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997; 3: 306-12.